Company Shandong Sinobioway Biomedicine Co., Ltd.

Company Shandong Sinobioway Biomedicine Co., Ltd.

002581

CNE1000012Y5

Pharmaceuticals

Equities

002581

CNE1000012Y5

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sector Biopharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sector Biopharmaceuticals

SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD.

End-of-day quote Shenzhen S.E. Other stock markets 18:00:00 2024-05-09 EDT			5-day change	1st Jan Change
13.35 ^CNY	-2.48%		-3.26%	-8.56%

04-29	Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-29	Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Shandong Sinobioway Biomedicine Co Ltd, formerly Zibo Wanchang Science & Technology Co Ltd, is a China-based company principally engaged in the manufacturing of pharmaceuticals. The Company is engaged in the business of interferon, nerve growth factor, biopharmaceutical contract research organization (CRO)/pharmaceutical contract development and manufacturing enterprise (CDMO), vaccines and pharmaceutical intermediates. The Company's main products include anferon, encyclopedia, Corona Virus Disease2019 vaccine and others. The Company distributes its products within domestic market.

Number of employees: 666

CNY in Million	2022	Weight	2023	Weight	Delta
Pharmaceutical 99.1 %	356	99.7 %	426	99.1 %	+19.54%
Other Business 0.9 %	1	0.3 %	4	0.9 %	+347.03%

CNY in Million	2022	Weight	2023	Weight	Delta
China 100.0 %	357	100.0 %	430	100.0 %	+20.36%

Managers	Title	Age	Since
JiaLin Yue CEO	Chief Executive Officer	56	22-07-08
Yang Jun Liu DFI	Director of Finance/CFO	49	22-07-08
Hui Zhao BRD	Director/Board Member	55	22-04-09
Wen Jun Liu BRD	Director/Board Member	41	22-07-08
Xiaoru Shi IRC	Investor Relations Contact	-	-

Members of the board	Title	Age	Since
JiaLin Yue CEO	Chief Executive Officer	56	22-07-08
Xiu Yuan Yu BRD	Director/Board Member	62	15-10-12
Ai Hua Pan CHM	Chairman	66	15-12-14
De Shun Luo CHM	Chairman	59	15-12-14
Xue Ming Yan BRD	Director/Board Member	51	15-10-12
Wen Jie Yu BRD	Director/Board Member	45	22-08-21
Zhe Zheng BRD	Director/Board Member	40	22-08-21
Gui Yuan Huang BRD	Director/Board Member	32	22-08-21
Rong Fu Zhang BRD	Director/Board Member	59	22-08-21
Jianuo Zeng BRD	Director/Board Member	29	22-08-21

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	659,735,586	387,820,217 ( 58.78 %)	0	58.78 %

Name	Equities	%	Valuation
Bao Lin Gao 18.42 %	73,822,800	18.42 %	118 M ¥
Ting Bo Shi 1.923 %	7,708,422	1.923 %	12 M ¥
Xiao Dong Yang 1.268 %	5,080,100	1.268 %	8 M ¥
Hao Chen 1.259 %	5,047,600	1.259 %	8 M ¥
Heping Wang 1.155 %	4,630,260	1.155 %	7 M ¥
Yan Zhen Zhu 1.003 %	4,017,969	1.003 %	6 M ¥
Chang Qi Wang 0.6374 %	2,554,800	0.6374 %	4 M ¥
Shiyu Liu 0.5814 %	2,330,000	0.5814 %	4 M ¥
Ming Xian Wang 0.1996 %	800,000	0.1996 %	1 M ¥
Zhejiang Yueshang Equity Investment Co. Ltd. 0.1622 %	650,196	0.1622 %	1 M ¥

Name	Equities	%	Valuation
Shenzhen Jialian Private Equity Fund Management Co. Ltd. 12.36 %	32,000,000	12.36 %	51 M ¥
Shenzhen Dehaiwei Industry Co. Ltd. 9.733 %	25,204,000	9.733 %	40 M ¥
Heping Wang 6.457 %	16,719,418	6.457 %	27 M ¥
Zhejiang Yueshang Equity Investment Co. Ltd. 4.803 %	12,438,234	4.803 %	20 M ¥
Zuo Ping Zheng 3.321 %	8,600,000	3.321 %	14 M ¥
Zhongnan Growth Tianjin Equity Investment Fund Partnership LP 3.253 %	8,423,039	3.253 %	13 M ¥
Xi Ping Ke 1.908 %	4,940,000	1.908 %	8 M ¥
Liu Kelly 0.9268 %	2,400,000	0.9268 %	4 M ¥
Ai Hua Pan 0.3862 %	1,000,000	0.3862 %	2 M ¥

Shandong Sinobioway Biomedicine Co., Ltd.

Rm 2005, No. 22 Keji South 12th Rd

518057, Shenzhen

address Shandong Sinobioway Biomedicine Co., Ltd.(002581)

	1st Jan change	Capi.
SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD.	-8.56%	1.22B
CSL LIMITED	-2.61%	89.08B
SAMSUNG BIOLOGICS CO.,LTD.	+3.55%	40.9B
BIOGEN INC.	-14.40%	32.25B
UCB	+55.89%	25.14B
BIOMARIN PHARMACEUTICAL INC.	-15.96%	15.39B
INCYTE CORPORATION	-15.50%	11.91B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-41.29%	11.89B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-11.75%	11.64B
SWEDISH ORPHAN BIOVITRUM AB	+7.87%	9.03B

Biopharmaceuticals

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Biopharmaceuticals